S'abonner

Factors of health in the protection against death and cardiovascular disease among adults with subclinical atherosclerosis - 11/04/18

Doi : 10.1016/j.ahj.2017.10.026 
Mahmoud Al Rifai, MD, MPH a, b, Philip Greenland, MD c, Michael J. Blaha, MD, MPH b, Erin D. Michos, MD, MHS b, Khurram Nasir, MD, MPH b, d, Michael D. Miedema, MD, MPH e, Joseph Yeboah, MD, MPH f, Veit Sandfort, MD g, Alexis C. Frazier-Wood, PhD h, Steven Shea, MD, MS i, Joao AC Lima, MD, MBA j, Moyses Szklo, MD, DrPH k, Wendy S. Post, MD, MS b, Roger S. Blumenthal, MD b, John W. McEvoy, MB, BCh, BAO, MEHP, MHS b,
a Department of Medicine, University of Kansas School of Medicine, Wichita, KS 
b Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University School of Medicine, Baltimore, MD 
c Departments of Preventive Medicine and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 
d Center for Prevention and Wellness, Baptist Health South Florida, Miami, FL 
e Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN 
f Department of Cardiology, Wake Forest Baptist Health, Winston-Salem, NC 
g National Institutes of Health, Bethesda, MD 
h ARS/USDA Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 
i Departments of Medicine and Epidemiology, Columbia University, New York, NY 
j Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 
k Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 

Reprint requests: John W. McEvoy, MB, BCh, BAO, MEHP, MHS, Assistant Professor of Medicine, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Division of Cardiology, Johns Hopkins University School of Medicine, 600 N Wolfe St, Blalock 524C, Baltimore, MD 21287, USA.Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Division of CardiologyJohns Hopkins University School of Medicine600 N Wolfe St, Blalock 524CBaltimoreMD21287USA

Abstract

Background

Although cardiovascular disease (CVD) prevention traditionally emphasizes risk factor control, recent evidence also supports the promotion of “health factors” associated with cardiovascular wellness. However, whether such health factors exist among adults with advanced subclinical atherosclerosis is unknown. We aimed to study the association between health factors and events among persons with elevated coronary artery calcium (CAC).

Methods

Self-reported health-factors studied included nonsmoking, physical activity, Mediterranean-style diet, sleep quality, emotional support, low stress burden, and absence of depression. Measured health-factors included optimal weight, blood pressure, lipids, and glucose. Multivariable-adjusted Cox models examined the association between health factors and incident CVD or mortality, independent of risk factor treatment. Accelerated failure time models assessed whether health factors were associated with relative time delays in disease onset.

Results

Among 1,601 Multi-Ethnic Study of Atherosclerosis participants with CAC >100 without baseline clinical atherosclerotic CVD, mean age was 69 (±9) years, 64% were male, and median CAC score was 332 Agatston units. Over 12 years of follow-up, nonsmoking, high-density lipoprotein cholesterol levels >40 mg/dL for men and >50 mg/dL for women, and low stress burden were inversely associated with ASCVD (hazard ratios ranging from 0.58 to 0.71, all P<.05). Nonsmoking, glucose levels <100 mg/dL, regular physical activity, and low stress burden were inversely associated with mortality (hazard ratios ranging from 0.40 to 0.77, all P<.05). Each of these factors was also associated with delays in onset of clinical disease, as was absence of depression.

Conclusions

Adults with elevated CAC appear to have healthy lifestyle options to lower risk and delay onset of CVD, over and above standard preventive therapies.

Le texte complet de cet article est disponible en PDF.

Plan


 Registration: ClinicalTrials.gov NCT00005487
 Supplementary information is provided in an Online Appendix. Disclosures are provided in the submission documents.


© 2017  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 198

P. 180-188 - avril 2018 Retour au numéro
Article précédent Article précédent
  • Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time—A RE-LY trial analysis
  • Ziad Hijazi, Stefan H. Hohnloser, Jonas Oldgren, Ulrika Andersson, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Paul A. Reilly, Salim Yusuf, Lars Wallentin
| Article suivant Article suivant
  • Government continues to have an important role in promoting cardiovascular health
  • Gordon Tomaselli, William H. Roach, Ileana L. Piña, Matthew E. Oster, William H. Dietz, Katie Horton, William B. Borden, Kelly Brownell, Raymond J. Gibbons, Jennifer J. Otten, Christopher S. Lee, Charles Hill, Paul A. Heidenreich, David S. Siscovick, Laurie P. Whitsel

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.